Foster Dykema Cabot & Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$68M |
| 2 |
KKR & Co
KKR
|
+$21.4M |
| 3 |
NVIDIA
NVDA
|
+$20M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$6.09M |
| 5 |
Synopsys
SNPS
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$19.2M |
| 2 |
Prologis
PLD
|
+$14.9M |
| 3 |
Eli Lilly
LLY
|
+$7.59M |
| 4 |
Amazon
AMZN
|
+$737K |
| 5 |
Genpact
G
|
+$695K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Industrials | 10.98% |
| 3 | Financials | 9.48% |
| 4 | Healthcare | 6.33% |
| 5 | Consumer Discretionary | 6.16% |
Similar funds
Foster Dykema Cabot & Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Foster Dykema Cabot & Partners held 522 positions worth $1.28B, up 7.7% from $1.19B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Foster Dykema Cabot & Partners deployed $87.5M of net new capital in Q4 2024, opening 2 new positions and adding to 59 existing holdings. Its largest new stake was SentinelOne: 1,804 shares worth $40K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Accenture, an estimated $19.2M trimmed.
- Foster Dykema Cabot & Partners's largest Q4 2024 buy was SentinelOne: 1,804 shares worth $40K.
- Foster Dykema Cabot & Partners added most to iShares Ultra Short Duration Bond Active ETF in Q4 2024, an estimated $68M increase.
- Foster Dykema Cabot & Partners's biggest Q4 2024 reduction was Accenture, cutting an estimated $19.2M.
- Foster Dykema Cabot & Partners fully exited Genpact in Q4 2024, selling an estimated $695K.
- Foster Dykema Cabot & Partners's ten largest holdings make up 60% of its $1.28B portfolio in Q4 2024.
- Foster Dykema Cabot & Partners opened 2 new positions and closed 142 in Q4 2024.
- Foster Dykema Cabot & Partners's portfolio value rose 7.7% quarter-over-quarter to $1.28B.
Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2024, filed 13 Feb 2025.